Amsurg Corp  

(Public, NASDAQ:AMSG)   Watch this stock  
Find more results for AMSG
35.96
-0.08 (-0.22%)
May 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 35.61 - 36.10
52 week 25.00 - 36.48
Open 35.95
Vol / Avg. 113,127.00/179,942.00
Mkt cap 1.15B
P/E 17.64
Div/yield     -
EPS 2.04
Shares 31.90M
Beta 0.94
Inst. own 99%
Jul 19, 2013
Q2 2013 AmSurg Corporation Earnings Release Add to calendar
May 30, 2013
AmSurg Corporation at Deutsche Bank dbAccess Health Care Conference - 10:00AM EDT - Add to calendar
May 23, 2013
AmSurg Corporation Annual Shareholder Meeting
May 15, 2013
AmSurg Corporation at Bank of America Merrill Lynch Health Care Conference - Webcast
Apr 24, 2013
Q1 2013 AmSurg Corporation Earnings Conference Call - Webcast
Apr 23, 2013
Q1 2013 AmSurg Corporation Earnings Release
Mar 13, 2013
AmSurg Corporation at Barclays Healthcare Conference - Webcast
Feb 27, 2013
AmSurg Corporation at Citi Global Healthcare Conference - Webcast
Feb 25, 2013
Q4 2012 AmSurg Corporation Earnings Conference Call - Tentative
Feb 25, 2013
Q4 2012 AmSurg Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 23.95% 23.95%
Operating margin 31.58% 30.37%
EBITD margin - 33.59%
Return on average assets 12.22% 12.29%
Return on average equity 10.29% 9.59%
Employees 4,000 -
Carbon Disclosure Rating - -

Address

Suite 500, 20 Burton Hills Boulevard
NASHVILLE, TN 37215
United States - Map
+1-615-6651283 (Phone)
+1-615-6650755 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

AmSurg Corp. is the owner and operator of short stay ambulatory surgery centers (ASCs) in the United States. An AmSurg surgery centers are typically located adjacent to or in close proximity to the medical practices of its partner physicians. Its surgical facilities primarily provide non-elective, high volume, lower-risk surgical procedures across multiple specialties, including among others gastroenterology, ophthalmology, and orthopedics. For the year ended December 31, 2012, approximately 1.5 million surgical procedures were performed in its ASCs. As of December 31, 2012, the Company operated 240 ASCs, of which the Company owned a majority interest in 235 ASCs and a minority interest in five ASCs (three of which are consolidated). During December 31, 2012, 149 centers performed gastrointestinal endoscopy procedures, 48 centers performed procedures in multiple specialties, 36 centers performed ophthalmology surgery procedures, and seven centers performed orthopedic procedures.

Officers and directors

Steven I. Geringer Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Christopher A. Holden President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Claire M. Gulmi Chief Financial Officer, Executive Vice President, Secretary, Director
Age: 59
Bio & Compensation  - Reuters
Phillip A. Clendenin Executive Vice President - Operations
Age: 48
Bio & Compensation  - Reuters
David L. Manning Executive Vice President, Chief Development Officer
Age: 63
Bio & Compensation  - Reuters
Kevin Delon Eastridge Senior Vice President - Finance, Chief Accounting Officer
Age: 47
Bio & Compensation  - Reuters
Billie Aileen Payne Senior Vice President - Operations
Age: 61
Bio & Compensation  - Reuters
Shawn G. Strash Senior Vice President - Corporate Services
Age: 50
Bio & Compensation  - Reuters
Thomas G. Cigarran Independent Director
Age: 70
Bio & Compensation  - Reuters
James A. Deal Independent Director
Age: 62
Bio & Compensation  - Reuters